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N-glycans and lipids are structural metabolites that play important roles in
cellular processes. Both show unique regional distribution in tissues; therefore,
spatial analyses of these metabolites are crucial to our understanding of cellular
physiology. Matrix-assisted laser desorption/ionization-mass spectrometry im-
aging (MALDI-MSI) is an innovative technique that enables in situ detection of
analytes with spatial distribution. This workflow details a MALDI-MSI protocol
for the spatial profiling of N-glycans and lipids from tissues following application
of enzyme and MALDI matrix.
For complete details on the use and execution of this protocol, please refer to
Drake et al. (2018) and Andres et al. (2020).
BEFORE YOU BEGIN
The workflow described in this protocol takes several days and requires careful preparation of re-
agents and access to specific equipment (see Materials and equipment). This protocol can be adapt-
ed to both formalin-fixed paraffin-embedded (FFPE) (N-glycans) and fresh frozen tissues (lipid spe-
cies) for MALDI-MSI analyses. Here, we describe the step-by-step process usingmouse brain tissues;
however, it can be applied to a large range of tissues.
Tissue processing and slide preparation of formalin-fixed paraffin-embedded (FFPE) tissues
Timing: can be done up to 1 month in advance
1. Process and embed tissue samples (Figure 1A)
a. Fix and process tissue
i. Place fresh tissue in formalin
ii. After 24 h, transfer tissue to 70% ethanol
iii. Place tissue in a cassette and dehydrate with increasing concentrations of ethanol
(70%–100%)
70% ethanol for 40 min
90% ethanol for 40 min
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95% ethanol for 40 min
100% ethanol for 40 min, 33
iv. Permeate the tissue with xylene to dissolve ethanol for 40 min
v. Displace the xylene with paraffin wax for 40 min, 33
b. Place tissue specimen into a mold of paraffin wax and solidify on a cold plate to create a
paraffin-embedded tissue block
2. Tissue cutting (Figure 1B)
a. Load tissue block onto a microtome
b. Cut slices at 4 mm thickness and place tissue ribbon in a cooled water bath
c. Transfer tissue slice to a positively charged glass slide
Tissue processing and slide preparation (fresh frozen tissues)
Timing: can be done up to 1 month in advance
3. Tissue collection and sectioning (Figure 2A)
a. Dissection and gradual freezing of the tissue
i. Prepare a bath of isopentane over dry ice and wait for it to equilibrate to about 70C
ii. Place the dissected tissue in an aluminum covered weigh boat on the isopentane-dry ice
bath for 7 min to freeze tissue. Larger samples may require additional time.
Note: Ensure complete freezing by checking the color or the tissue. Frozen tissue appears
paler than raw tissue.
iii. Place tissue into foil packet and drop into liquid nitrogen for 1 min
iv. Store at 80C
b. Sectioning the tissue (Figure 2B)
i. Prepare cryostat by turning the internal temperature down to 23C
ii. Place a small amount of OCT (optimal cutting temperature compound) on the cryostat
chuck and place the tissue on the OCT
CRITICAL: Ensure that no OCT is on the tissue sections. OCT is ion suppressive and will
interfere with lipid analysis.
Figure 1. Processing, embedding, and sectioning FFPE tissue samples
(A) Tissues are formalin fixed in a cassette, followed by embedding in paraffin wax.
(B) Paraffin blocks are sectioned at 4 mm onto positively charged slides.
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iii. Allow the OCT and tissue to sit for 2 min inside the cryostat to ensure solidification
iv. Cut sections at 4–10 mm utilizing the plastic wedge to ensure even sections
v. Lift the wedge and touch slide to mount the freshly cut tissue section onto a positively
charged slide
vi. Store slides at 80C
Note: Fresh frozen tissue slices do not require dewaxing, antigen retrieval, or enzyme appli-
cation. As such, steps 4–6 of Before you begin may be skipped.
Preparation of dewaxing solutions, humidity chamber, and antigen retrieval device
Timing: 0.5–1 h





e. Deionized water (23)
Figure 2. Freezing and sectioning fresh frozen tissue samples
(A and B) (A) Tissues are slow frozen in an isopentane bath and (B) sectioned at 4 mm onto positively charged slides
using a cryostat.
(C) Example of fresh (left) and frozen (right) mouse brain tissue.
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Note: Fresh dewaxing solutions are critical for complete removal of paraffin wax and should
be prepared fresh for every 10 slides processed.
5. Prepare humidity chamber for PNGase F digestion (Figure 3A)
a. Wet one paper towel and place in humidity chamber
b. Place humidity chamber in oven (38.5C) at least 1 h prior to PNGase F digestion
6. Prepare water bath steamer for antigen retrieval by filling with tap water to fill line and preheating
for 5 min prior to antigen retrieval (Figure 3B)
KEY RESOURCES TABLE
Figure 3. Preparation of humidity chamber for PNGase F digestion and water bath steamer for antigen retrieval
(A) Prepare humidity chamber in oven 1 h prior to PNGase F digestion.
(B) Prior to antigen retrieval, prepare water bath steamer (top). When ready, place mailer in top basket of steamer with
slides facing inward (bottom).
REAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals, peptides, and recombinant proteins
Xylene Spectrum CAS#: 1330-20-7
Ethanol Decon Labs CAS#: 64-17-5
HPLC water Sigma-Aldrich CAS#: 7732-18-5
Hydrochloric acid LabChem CAS#: 7647-01-0
Citraconic anhydride Thermo Scientific CAS#: 616-02-4
Horseradish Peroxidase Sigma-Aldrich CAS#: 9003-99-0
PNGase F N-Zyme Scientifics Lot: NZL-2020-0194
a-Cyano-4-hydroxycinnamic acid Cayman Chemical CAS#: 28166-41-8
Trifluoroacetic acid Sigma-Aldrich CAS#: 76-05-1
Acetonitrile Sigma-Aldrich CAS#: 75-05-8
Methanol Sigma-Aldrich CAS#: 67-56-1
Software and algorithms
High Definition Imaging (HDI) Software Waters Catalog #: 720005652EN
(Continued on next page)
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MATERIALS AND EQUIPMENT
Citraconic anhydride buffer: add 25 mL of Citraconic Anhydride and 2 mL of 12 M HCl to 50 mL of
HPLC grade water in a 50 mL falcon tube. Vortex and confirm pH of 3.0 G 0.5.
PNGase F solution: Enzyme is supplied in lyophilized 100 mg aliquots. To prepare, quick spin to
pellet enzyme and add 50 mL of HPLC water. Vortex for 10 s and add 950 mL of HPLC grade water.
Prepare fresh on the same day.
a-Cyano-4-hydroxycinnamic acid (CHCA) matrix (7 mg/mL): Weigh 40 mg of CHCA in a 15 mL falcon
tube using a clean and dry spatula. Add 5.7 mL of 50% acetonitrile/0.1% TFA. Vortex and sonicate
for 10 min at 89 s on, 30 s off. Prepare fresh on the same day.
CRITICAL: It is important to clean the CHCA spatula with methanol, ethanol, or HPLC wa-
ter only, do not use detergent. Detergent can significantly interfere with N-glycan and
lipid ionization and detection, leading to poor signal.
Alternatives: This protocol is optimized using the equipment specified above in the Key
resources table, but they are not exclusive products to carry it out. If any materials or equip-
ment are modified, further optimization is highly recommended as there is no guarantee that
any change would not alter ionization efficiency and/or sensitivity of the mass spectrometer.
STEP-BY-STEP METHOD DETAILS
Slide preparation and antigen retrieval (day 1)
Timing: 2–3 h
Note: If analyzing lipids from fresh frozen tissue, remove slides from80C and bring to 20C
in a vacuum desiccator for 2 h. Proceed to step 9 for CHCA matrix application.
1. Heat slides
a. Heat slides for 1 h in 60C oven with small water bath, tissue side up
b. After 1 h, remove slides and allow to cool to 20C for 1 min
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Other
INCU-Line IL 10 digital incubator VWR Catalog #: VWRI390-0384
Hsw Norm-Ject Sterile Luer-Lock syringe, 3 mL VWR Catalog #: 53548-017
SGE syringe, gas tight plunger, 5 mL VWR Catalog #: 60361-204
Millipore Sigma non-sterile syringe filter, 13 mm, 0.20 mm Fisher Scientific Catalog #: SLLGX13NL
M.5 humid chamber HTX Technologies N/A
Simport Scientific EasyDip slide staining rack VWR Catalog #: 87000-132
Simport Scientific EasyDip slide staining jars VWR Catalog #: 87000-124
Charged microscope slides VWR Catalog #: 89500-516
11 L vacuum desiccator SP Bel-Art Scienceware Catalog #: F42400-4101
Bioruptor Pico sonication device Diagenode Catalog #: B01060010
Cryo-Cube F740hi Eppendorf Catalog #: F740220035
M5 high-velocity sprayer HTX Imaging N/A
Azura P 4.1S HPLC pump Knauer Article #: APG20EA
‘‘Just Infusion’’ syringe pump New Era Pump Systems Model: NE-300
MALDI Synapt XS Waters Catalog #: 720006589
Perfection V600 photo scanner Epson Model #: B11B198011
Water bath steamer Rival Model #: CKRVSTLM21
ll
OPEN ACCESS
STAR Protocols 2, 100304, March 19, 2021 5
Protocol
2. Dewax slides
a. Place slides in slide holder and wash in dewaxing solutions for the following times:
i. Xylenes for 3 min, 23
ii. 100% ethanol for 1 min, 23
iii. 95% ethanol for 1 min
iv. 70% ethanol for 1 min
v. Deionized water for 3 min, 23
b. Dry slides in vacuum desiccator for 8 min
Note: Antigen retrieval denatures and breaks protein crosslinks that were formed during
fixation, allowing greater enzymatic access to proteins within the sample.
3. Antigen retrieval
a. Ensure that the water bath steamer is preheated
b. Place no more than two slides in a 5-slide holder with side opening partially closed
Note: Slides should be placed with tissue facing inward in the first and last slide slot to ensure
that tissue is not touching the inner walls of the holder.
c. Fill holder with citraconic anhydride buffer
d. Incubate in water bath steamer for 30 min
5. Application of positive control
a. 1 mL of positive control (horseradish peroxidase) can be spotted directly onto the slide adja-
cent to tissue
Note: Controls can include a glycosylated protein or purified glycans.
6. Dry slides for 15 min in vacuum desiccator
PNGase F application by HTX M5 sprayer
Timing: 3–4 h, done immediately following slide preparation and antigen retrieval
PNGase F cleaves N-linked glycans from their carrier proteins. Use of the HTX M5 sprayer ensures
even application of enzyme, allowing for consistency to improve rigor and reproducibility. This
methodology preserves spatial localization for MALDI-MSI analysis of N-glycan distribution. Incuba-
tion in a humidity chamber allows for maximum cleavage of N-glycans by PNGase F (see Trouble-
shooting 1).
7. Application of PNGase F (Figures 4A–4C)
a. Turn on HTX M5 Sprayer
b. Turn on nitrogen gas and stabilize pressure to 10 psi
i. Adjust pressure using dial on sprayer
c. Open HTX M5 software on controlling computer and confirm the following settings:
i. Set point temperature: 45C
ii. Tray type: Ambient
d. Turn off Knauer pump and disconnect from sprayer
e. Turn on syringe pump and connect to sprayer
Note: It is recommended to clean the syringe pump enzyme line before each application
of PNGase F. Load 3 mL of HPLC water into a clean syringe and set the pump rate to
95 mL/min. Start the syringe pump, and let water flow through the sprayer for 5 min prior to
loading PNGase F solution.
ll
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f. Setting up samples
i. Arrange slides on the sprayer stage
ii. On controlling computer, change the XY parameters to define the spraying area
g. Load PNGase F solution
i. Using a clean syringe, draw up PNGase F and remove any bubbles
ii. Attach syringe to 6’’ enzyme line and connect line to the sprayer
iii. Place syringe in the syringe pump and lock in place
CRITICAL: Bubbles in solution will interfere with even enzyme application. See Trouble-
shooting section.
h. PNGase Application (Figure 4D)
i. Set syringe pump flow rate to 25 mL/min and syringe diameter to 9.7 mm
Note: Confirm syringe diameter if not using Hsw Norm-Ject Sterile Luer-Lock Syringe (see
Key resources table).
ii. Start the syringe pump and confirm even sprayer application on test slide
iii. Once even spraying is confirmed, press start on the controlling computer to begin spray-
ing across sample slides
iv. Monitor spray to ensure even PNGase F application across sample slides
v. When the cycle has completed, press stop on the syringe pump and remove slides from
the tray
vi. Place slides tissue side up in basket of humidity chamber and cover with lid
Figure 4. Overview of HTX M5 sprayer setup
(A) HTX M5 sprayer connected to controlling computer, syringe pump, and Knauer pump with CHCA loading syringe shown.
(B) External sprayer connectors on the left of the HTX M5 sprayer.
(C) Internal sprayer connectors on the inside of the HTX M5 sprayer.
(D) Syringe pump loaded with syringe locked in place. Label key: (1) controlling computer, (2) syringe pump, (3) Knauer
pump, (4) CHCA loading syringe, (5) enzyme line, (6) Knauer line, (7) sprayer nozzle, and (8) stage.
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vii. Incubate the samples for PNGase F digestion in preheated humidity chamber for 2 h
viii. Dry slides in a vacuum desiccator for a minimum of 15 min, or up to 24 h
Note: It is recommended to clean the HTX M5 sprayer after each application of PNGase F
by lowering the set temperature to 35C and flushing the enzyme line with HPLC water at
a flow rate of 95 mL/min. After cleaning, the sprayer program, gas, and syringe sprayer
can be turned off. Reattach the Knauer pump to the sprayer and set the Knauer pump
to a flow rate of 100 mL/min.
CRITICAL: Slides must lie flat in the humidity chamber and must be completely dried
prior to CHCA matrix application. This ensures spatial localization of cleaved glycans is
maintained.
Pause point: After incubation, slides can remain in desiccator for up to 24 h. Matrix applica-
tion can be done on day 2.
CHCA matrix application by HTX M5 sprayer (day 1 continued or day 2)
Timing: 0.5–1 h
Application of the CHCA matrix facilitates ionization of the cleaved N-glycans, ensuring sufficient
signal intensity. Use of the HTX M5 sprayer ensures even application of CHCA matrix, allowing for
consistent sample ionization across tissue regions (see Troubleshooting 1).
8. Prepare the CHCA matrix
a. Prepare matrix at 7 mg/mL in 50% acetonitrile/0.1% TFA
b. Filter the CHCA solution using a 0.2 mm syringe filter
Note: Carefully filter the CHCA solution as undissolved CHCA can clog components of the
HTX M5 sprayer.
9. Application of CHCA matrix (Figures 4A–4C)
a. Scan slides in slide holder with a scanner before application of matrix
Note: A scanned image of the slide in the slide holder is used to program tissue regions to be
analyzed by MALDI-MSI. Scanning prior to CHCA matrix application yields a clearer image of
tissue boundaries.
b. Turn on the HTX M5 sprayer
i. Turn on nitrogen gas and stabilize pressure to 10 psi and adjust pressure using dial on
sprayer
c. Open HTX M5 software on controlling computer and confirm the following settings:
i. Set point temperature: 79C
ii. Tray temperature: 50C
iii. Pump flow rate: 100 mL/min
d. Prime the Knauer pump
i. Unscrew black cap on the front of pump and pull degassed 50%methanol through using the
attached syringe. Return the black cap and discard the methanol.
e. Clean the sprayer line
i. In the ‘‘LOAD’’ position, remove the stopper syringe and flush the line with 5 mL of 50%
acetonitrile. Immediately replace with stopper syringe. With drip catcher below the sprayer
nozzle, switch to ‘‘SPRAY’’ position and flush the line for 5 min.
f. Load the CHCA matrix solution
i. Draw up filtered CHCA into clean syringe and remove all bubbles.
ll
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ii. In the ‘‘LOAD’’ position, remove the stopper syringe and expel the CHCA into the sprayer
line. Immediately replace the stopper syringe.
Note: Bubbles the sprayer line will interfere with even CHCA matrix application. See Trouble-
shooting section.
g. Setting up samples
i. Arrange slides on the sprayer stage
ii. On controlling computer, change the XY parameters to define the spraying area
h. CHCA matrix application
i. Ensure that drip catcher is below the sprayer nozzle and switch sprayer position from
‘‘LOAD’’ to ‘‘SPRAY.’’
ii. Confirm that the temperature has reached 79C and flow rate is 100 mL/min.
iii. Start the Knauer pump and confirm even sprayer application on test slide
iv. Once even spraying is confirmed, press start on the controlling computer to begin spray-
ing across sample slides
v. Monitor spray to ensure even CHCA matrix application across all slides
vi. Once the application is complete, switch sprayer back to ‘‘LOAD’’ position
vii. Remove slides and lay flat to dry. Slides can be immediately analyzed by MALDI-MSI or
stored in a vacuum desiccator at 20C for up to 1 week.
Note: It is highly recommended to clean the HTX M5 sprayer after each CHCA matrix applica-
tion. With the nitrogen gas still on, change the sprayer set point temperature and tray temper-
ature to 30C, and adjust the Knauer pump flow rate to 300 mL/min using the controlling com-
puter. While the sprayer cools down, switch the sprayer to ‘‘load,’’ flush the line with 5 mL of
50% acetonitrile twice. Repeat line flush with 50% methanol twice. Switch sprayer to ‘‘spray’’
and allow 50%methanol to run through the line until the set point temperature and tray temper-
ature reach 30C, then switch the sprayer back to the ‘‘load’’ position. Adjust the Knauer pump
flow rate back to 100 mL/min, return the drip catcher to below the sprayer nozzle, and turn off the
nitrogen gas. Any residual CHCA matrix on the slide stage can be removed with 50% methanol.
Image acquisition by waters synapt G2-XS mass spectrometer
The parameters indicated in Tables 1, 2, and 3 are used for N-glycan and lipid analysis on a Waters
Synapt G2-XS Mass Spectrometer and can be programmed in the HDI software.
Note: Proper laser firing is essential for sufficient ionization of the CHCA matrix, as well as
N-glycans and lipids. As laser energy can decrease with time, it is recommended to confirm
the laser is performing properly. We recommend testing laser firing on a slide coated with
CHCA matrix only and confirming the signal intensity of CHCA matrix peaks. For these ana-
lyses, the laser used in this manuscript was approximately 6 months old.
EXPECTED OUTCOMES
In our experimental protocol, we describe a detailedmethod for visualization of N-glycans and lipids
from FFPE and fresh frozen tissue, respectively, by MALDI-MSI. Typically, for most mammalian tis-
sues, the Waters Synapt G2 mass spectrometer detects over 120 N-glycan and 200 lipid peaks, de-
pending on the complexity and quality of the tissue. Here, we illustrate an example of the protocol to
Table 1. MALDI laser settings for analysis of N-glycans and lipids
N-Glycans Lipids
Laser energy 250 mJ 200 mJ
Laser firing rate 1,000 Hz 1,000 Hz
Raster size 50–200 mm 50–200 mm
Time per pixel 0.5 s 0.5 s
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visualize N-glycans (Figure 5) and lipids (Figure 6) from a wild-type mouse brain using the HDI imag-
ing software. Glycan and lipids were assigned based on previously established reports (Colsch and
Woods, 2010; Powers et al., 2014; Zhang et al., 2016; Drake et al., 2017, Drake et al., 2018). In both
cases, ion mobility improved N-glycan/lipid detection by separating their peaks from ionization ma-
trix based on differential collision cross section (see Troubleshooting 2).
QUANTIFICATION AND STATISTICAL ANALYSIS
Imaging
For the qualitative comparison of N-glycan and lipid species between two or more groups, N-glycan
and lipid masses should be normalized to total ion chromatograph (TIC) within each pixel. This will
correct for small batch variations introduced by CHCA concentration and laser power reduction over
time.
Regional analysis
For the qualitative analysis of regional abundance of N-glycans and lipids, first N-glycan and lipid
masses should be normalized to TIC within each pixel. Then regions of interest (ROI) should be
defined by the user. The number of pixels must be consistent between ROIs of two or more groups
before exportation of mass spectrometry data. The appropriate statistical analysis for comparison
between two more groups should be determined by the user. These include but are not limited
to: student’s T-test, ANOVA, clustering heat analysis, and principal component analysis.
LIMITATIONS
This protocol requires high quality tissue samples to be properly prepared prior to MALDI-MSI anal-
ysis. Tissues not fixed or frozen in a timely manner risk degradation, and tissue sections that are cut
higher than the recommended thickness can result in poor quality images. It is also recommended to
use recently sectioned tissue, as tissue that has been cut less than 30 days prior yields better sample
ionization and signal.
Use of this protocol for N-glycan profiling requires consistency in PNGase F enzymatic activity across
sample preparations to ensure reproducible results. Maintaining proper oven temperature and hu-
midity during PNGase F digestion, and the use of a positive control are key to confirming enzymatic
activity. It is recommended to use PNGase F from the same vendor and lot number to ensure consis-
tent N-glycan cleavage (see also Troubleshooting 3). PNGase F should be stored in single use ali-
quots in a 80C freezer. Further, certain commercially available PNGase F frequently contains
Table 2. Mass spectrometer settings for analysis of N-glycans and lipids
N-Glycans Lipids
Trap collision energy 4 V 4 V
Transfer cell collision energy 2 V 2 V
Scan rate 0.5 s 0.5 s
Polarity Positive Negative
Analyzer mode Sensitive Sensitive
Mass range m/z 500–3,500 50–2,500
Table 3. Ion mobility settings for analysis of N-glycans and lipids
N-Glycans Lipids
Trap Entrance 2 V; bias 85 V, trap DC 0 V; exist 0 V Entrance 2 V; bias 75 V, trap DC 0 V; exist 0 V
Wave velocity Trap 9.6 m/s; IMS 4.6 m/s; transfer 17.4 m/s Trap 9.6 m/s; IMS 4.6 m/s; transfer 17.4 m/s
Wave height Trap 4 V; IMS 42.7 V; transfer 4 V Trap 4 V; IMS 42.7 V; transfer 4 V
Variable wave
Velocity mode
Ramp down; 1,400 m/s (start)-300 m/s (end) Ramp down; 1,400 m/s (start)-300 m/s (end)
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additives such as glycerol and high salt concentrations that will interfere with the ionization and
detection of N-glycans. Such additives will require removal by dialysis.
TROUBLESHOOTING
Problem 1
Uneven PNGase F or CHCA matrix application.
Potential solution
Bubbles in the enzyme or matrix solution can interfere with even sprayer application andmaintaining
pressure in both the syringe and Knauer pumps. When loading solution into the syringe, make sure
to pull the plunger up slowly to reduce the number of bubbles. Once the solution is in the syringe,
gently tap it against a hard surface to push bubbles to the top and expel the air. Further, residual
CHCAmatrix in the sprayer nozzle can crystallize and lead to the sprayer nozzle sputtering. Allowing
degassed 50% methanol to flow through the sprayer at 100 mL/min following cleaning, even when
the sprayer is not in use, prevents crystallization of any residual matrix in the sprayer line. If the pres-
sure in the Knauer pump fluctuates, this will cause the matrix spray to be uneven as well. This could
be caused by an air bubble in the front of the pump, so prime the pump again and pull about 10 mL
of methanol through the pump to get rid of the bubble.
Problem 2
Low signal across tissue.
Figure 5. PNGase F digestion and MALDI-MSI analysis of N-glycans in mouse brain tissue
(Top) 2D plot of monoisotopic mass versus drift time in the ion mobility cell for N-glycans and the MALDI matrix. (Bottom) Extracted ion chromatogram
of released N-glycans and matrix ions based on ion mobility separation for (A) both, (B) N-glycans, and (C) matrix. (D) Representative HDI images of 1809
m/z, 1581 m/z, 1905 m/z, and overlay image of 1809 m/z (red), 1581 m/z (green), and 1905 m/z (blue). Scale bar, 1.5 mm.
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Potential solution
For N-glycans, PNGase F activity can be checked by use of a positive control. Following antigen
retrieval, addition of a small amount of a protein such as horseradish peroxidase (known to be gly-
cosylated) onto the slide away from the tissue can be used to assess PNGase F activity. If N-glycan
signal is within range on the control protein, but not on the tissue sample, the dewaxing, or antigen
retrieval steps may need to be investigated, as insufficient dewaxing or antigen retrieval can block
enzymatic access to the N-glycans. If no signal was detected on the positive control, check PNGase F
solution for integrity or sprayer may be blocked.
For lipids, make sure tissue is 4–10 mm thickness. Tissue thicker than 10 mm decreases laser
ionization efficiency; 4 mm provides better ionization for gangliosides. Make sure CHCA is prepared
fresh daily and properly stored. Repeat freeze thawing cycle of CHCA will compromise ionization
efficiency.
Problem 3
Inconsistent N-glycan cleavage across the sample or poor detection of regional N-glycans.
Potential solution
This protocol requires that the tissue analyzed is sectioned evenly and of a specific thickness. Uneven
tissue samples produce inconsistent and variable results. Further, problems during PNGase F incu-
bation period can cause inconsistent enzymatic cleavage. Slides must remain flat in the humidity
chamber during incubation, as well as proper temperature and humidity must bemaintained. Ensure
that the paper towel in the chamber remains wet during incubation.
Figure 6. MALDI-MSI analysis of lipids in mouse brain tissue
(Top) 2D plot of monoisotopic mass versus drift time in the ion mobility cell for lipids and the MALDI matrix. (Bottom) Extracted ion chromatogram
of lipids and matrix ions based on ion mobility separation for (A) both, (B) lipids, and (C) matrix. (D) Representative HDI images of 1,573.2 m/z,
888.6 m/z, 885.7 m/z, and overlay image of 885.7 m/z (red), 1,573.2 m/z (green), and 888.6 m/z (blue). Scale bar, 1.5 mm. Gangliosides (GM1) (20:1/18:0),
3-o-sulfogalactosylceramide (SM4) (d18:1-C24:1), Phosphatidylinositol (PI) 38:4.
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Further information and requests for resources and reagents should be directed to and will be ful-
filled by the Lead Contact, Dr. Ramon C. Sun (ramon.sun@uky.edu).
Materials availability
This study did not generate new unique reagents.
Data and code availability
The published article includes all datasets generated or analyzed during this study.
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